September 13, 2012 / 6:21 PM / 5 years ago

BRIEF - Moody's affirms Valeant Pharmaceuticals International

Sept 13 (Reuters) - Moody’s affirms Valeant Pharmaceuticals International Ba3 rating; negative outlook

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below